SCHEMBL8694378

SCHEMBL8694378

[CH2]CCCOCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9122483 0.93 EPHX2 (0.40)
SCHEMBL5075002 0.91 CES2 (0.42)
SCHEMBL9123930 0.91 CES2 (0.42)
SCHEMBL691826 0.84
SCHEMBL10001230 0.84 CES2 (0.46)
SCHEMBL23405410 0.81 CES2 (0.44)
SCHEMBL7713583 0.81 CES2 (0.50)
SCHEMBL22922080 0.81 CES2 (0.44)
SCHEMBL18660231 0.81 CES2 (0.50)
SCHEMBL4566618 0.79 CES2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106421877-B The preparation method of antibacterial anti hemorrhagic microballoon of the one kind based on cellulose 北京理工大学 2019-08-02 CN claimed
CN-106421877-A Preparation method for antibacterial hemostatic microspheres based on cellulose 北京理工大学 2017-02-22 CN claimed
US-5077309-A Thromboxane a2 antagonist NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1991-12-31 US claimed
EP-0231078-B1 PROSTAGLANDINS NAT RES DEV (GB) 1990-04-25 EP claimed
EP-0231078-A2 Prostaglandins NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1987-08-05 EP claimed
WO-1987004428-A2 PROSTAGLANDINS NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1987-07-30 WO claimed
WO-1987004427-A2 PROSTAGLANDIN SYNTHESIS NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1987-07-30 WO claimed
EP-0230381-A2 Prostaglandin synthesis NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1987-07-29 EP claimed
EP-0208755-A1 THROMBOXANE ANTAGONISTS IN THE TREATMENT OF HORMONE-DEPENDENT NEOPLASIAS. NAT RES DEV (GB) 1987-01-21 EP claimed
WO-1986004234-A2 THROMBOXANE ANTAGONISTS IN THE TREATMENT OF HORMONE-DEPENDENT NEOPLASIAS NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1986-07-31 WO claimed
CN-106421877-B The preparation method of antibacterial anti hemorrhagic microballoon of the one kind based on cellulose 北京理工大学 2019-08-02 CN disclosed
CN-106421877-A Preparation method for antibacterial hemostatic microspheres based on cellulose 北京理工大学 2017-02-22 CN disclosed
WO-1998035677-A1 NON-SEDATING HISTAMINE ANTAGONIST COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF BRIDGE PHARMA, INC. (US) 1998-08-20 WO disclosed
US-5476848-A Antihistamines SANKYO COMPANY, LIMITED (JP) 1995-12-19 US disclosed
US-5461051-A Tetracyclic compounds having anti-allergic and anti-asthmatic activities and their use SANKYO COMPANY, LIMITED (JP) 1995-10-24 US disclosed
EP-0230381-A2 Prostaglandin synthesis NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1987-07-29 EP disclosed
EP-0208755-A1 THROMBOXANE ANTAGONISTS IN THE TREATMENT OF HORMONE-DEPENDENT NEOPLASIAS. NAT RES DEV (GB) 1987-01-21 EP disclosed
WO-1986004234-A2 THROMBOXANE ANTAGONISTS IN THE TREATMENT OF HORMONE-DEPENDENT NEOPLASIAS NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1986-07-31 WO disclosed
US-4486443-A PROSTAGLANDIN-LIKE EFFECTS BURROUGHS WELLCOME CO. (US) 1984-12-04 US disclosed
US-4262128-A HAVING PROSTAGLANDIN-LIKE BIOLOGICAL PROPERTIES BURROUGHS WELLCOME CO. (US) 1981-04-14 US disclosed